250
Participants
Start Date
May 11, 2022
Primary Completion Date
November 14, 2022
Study Completion Date
December 1, 2022
AlmegaPL (FDA NDIN # 826)
The investigational product iwi/Cholesterol is a commercially available capsule-form herbal (algae) supplement containing Almega®PL, a Nannochloropsis algae-derived extract rich in eicosapentaenoic acid (EPA). EPA is a type of omega-3 essential fatty acid known to play a beneficial role in protection against cardiovascular disease. Iwi/Cholesterol is the only source of long chain omega-3 that does not contain the DHA that is present in other omega-3 sources (fish oil, krill oil, other algal oils). Almega®PL was registered at the Food and Drug Administration (FDA) as a New Dietary Ingredient (NDIN) in 2014.
Qualitas Health, Houston
Arizona State University, Tempe
Arizona State University
OTHER
Qualitas Health
INDUSTRY